Cargando…

Identification of Candidate Biomarkers of Alzheimer’s Disease via Multiplex Cerebrospinal Fluid and Serum Proteomics

Alzheimer’s disease (AD) is the most prevalent form of dementia among elderly people worldwide. Cerebrospinal fluid (CSF) is the optimal fluid source for AD biomarkers, while serum biomarkers are much more achievable. To search for novel diagnostic AD biomarkers, we performed a quantitative proteomi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ping, Li, Lingxiao, He, Fangping, Meng, Fanxia, Liu, Xiaoyan, Su, Yujie, Su, Xinhui, Luo, Benyan, Peng, Guoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532410/ https://www.ncbi.nlm.nih.gov/pubmed/37762527 http://dx.doi.org/10.3390/ijms241814225

Ejemplares similares

Serum Metabolites Differentiate Amnestic Mild Cognitive Impairment From Healthy Controls and Predict Early Alzheimer's Disease via Untargeted Lipidomics Analysis
por: Zhang, Lumi, et al.
Publicado: (2021)

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
por: Khoonsari, Payam Emami, et al.
Publicado: (2016)

Alzheimer disease pathology and the cerebrospinal fluid proteome
por: Dayon, Loïc, et al.
Publicado: (2018)

Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease
por: Karayel, Ozge, et al.
Publicado: (2022)

Multiplex Analysis of Cytokines in the Serum and Cerebrospinal Fluid of Patients With Alzheimer's Disease by Color-Coded Bead Technology
por: Choi, Chulhee, et al.
Publicado: (2008)

Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
por: Bader, Jakob M, et al.
Publicado: (2020)

Classification and Interpretability of Mild Cognitive Impairment Based on Resting-State Functional Magnetic Resonance and Ensemble Learning
por: Hu, Mengjie, et al.
Publicado: (2022)

High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer’s Disease in Human Cerebrospinal Fluid
por: Hendrickson, Ronald C., et al.
Publicado: (2015)

Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics
por: Tijms, Betty M, et al.
Publicado: (2020)

Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
por: Wildsmith, Kristin R, et al.
Publicado: (2014)

Association of serum Apolipoprotein B with cerebrospinal fluid biomarkers of Alzheimer’s pathology
por: Hu, Hao, et al.
Publicado: (2020)

A Strategy for Discovery and Verification of Candidate Biomarkers in Cerebrospinal Fluid of Preclinical Alzheimer’s Disease
por: Zhong, Xiaofang, et al.
Publicado: (2019)

Cerebrospinal Fluid Biomarker Candidates for Parkinsonian Disorders
por: Constantinescu, Radu, et al.
Publicado: (2013)

Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach
por: van Steenoven, Inger, et al.
Publicado: (2020)

Longitudinal Bottom-Up Proteomics of Serum, Serum Extracellular Vesicles, and Cerebrospinal Fluid Reveals Candidate Biomarkers for Early Detection of Glioblastoma in a Murine Model
por: Greco, Francesco, et al.
Publicado: (2021)

Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients
por: Bai, Shumei, et al.
Publicado: (2009)

Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
por: Johnson, Erik C. B., et al.
Publicado: (2023)

Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease
por: Higginbotham, Lenora, et al.
Publicado: (2020)

Proteomics Study on the Cerebrospinal Fluid of Patients with Encephalitis
por: Xiong, Liu-Lin, et al.
Publicado: (2021)

Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer’s disease
por: Wang, Hong, et al.
Publicado: (2020)

MicroRNA-29a Is a Candidate Biomarker for Alzheimer’s Disease in Cell-Free Cerebrospinal Fluid
por: Müller, Mareike, et al.
Publicado: (2015)

Posterior cortical atrophy as a primary clinical phenotype of corticobasal syndrome with a progranulin gene rs5848 TT genotype
por: Peng, Guoping, et al.
Publicado: (2016)

Quantitative proteomics of delirium cerebrospinal fluid
por: Poljak, A, et al.
Publicado: (2014)

High-Multiplex Aptamer-Based Serum Proteomics to Identify Candidate Serum Biomarkers of Oral Squamous Cell Carcinoma
por: Blatt, Sebastian, et al.
Publicado: (2023)

Quantitative proteomics on the cerebrospinal fluid of hydrocephalus in neonatal bacterial meningitis
por: Chen, Juncao, et al.
Publicado: (2022)

Establishing the Proteome of Normal Human Cerebrospinal Fluid
por: Schutzer, Steven E., et al.
Publicado: (2010)

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
por: Konijnenberg, Elles, et al.
Publicado: (2020)

Cerebrospinal Fluid Proteome Alterations Associated with Neuropsychiatric Symptoms in Cognitive Decline and Alzheimer’s Disease
por: Mroczek, Magdalena, et al.
Publicado: (2022)

Identification of cerebrospinal fluid biomarker candidates for anti-N-methyl-D-aspartate receptor encephalitis: High-throughput proteomic investigation
por: Li, Yuchen, et al.
Publicado: (2022)

Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
por: Huynh, Rose Ann, et al.
Publicado: (2017)

Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome
por: Dekker, Alain D., et al.
Publicado: (2017)

A Multiplex Protein Panel Applied to Cerebrospinal Fluid Reveals Three New Biomarker Candidates in ALS but None in Neuropathic Pain Patients
por: Lind, Anne-Li, et al.
Publicado: (2016)

Quantification of microRNA-210 in the cerebrospinal fluid and serum: Implications for Alzheimer’s disease
por: ZHU, YAN, et al.
Publicado: (2015)

Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis
por: CHEN, YAN, et al.
Publicado: (2016)

Corrigendum: Quantitative proteomics on the cerebrospinal fluid of hydrocephalus in neonatal bacterial meningitis
por: Chen, Juncao, et al.
Publicado: (2023)

Methods to capture proteomic and metabolomic signatures from cerebrospinal fluid and serum of healthy individuals
por: Lilley, Laura M., et al.
Publicado: (2022)

Clinical and neuroimaging differences between posterior cortical atrophy and typical amnestic Alzheimer’s disease patients at an early disease stage
por: Peng, Guoping, et al.
Publicado: (2016)

Cerebrospinal Fluid Biomarker Candidates Associated with Human WNV Neuroinvasive Disease
por: Fraisier, Christophe, et al.
Publicado: (2014)

Cerebrospinal Fluid in Classical Trigeminal Neuralgia: An Exploratory Study on Candidate Biomarkers
por: Svedung Wettervik, Teodor, et al.
Publicado: (2022)

Label-free Quantitative Proteomic Analysis of Cerebrospinal Fluid and Serum in Patients With Relapse-Remitting Multiple Sclerosis
por: Liu, Haijie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_484gn5lvr5pee39vss9n5q1v91